PTGS2 and cancer: Cyclooxygenase-2 (COX-2) inhibition is often regarded as the pharmacological basis responsible for the anti-inflammatory properties of NSAIDs, which is also considered to be the mechanism responsible for the cancer chemopreventive activity of NSAIDs [8, 9].